Identifying Different Causes of Hyponatremia With Fractional Excretion of Uric Acid
Overview
Affiliations
Background: There is controversy over the prevalence of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral or renal salt wasting (RSW), 2 syndromes with identical common clinical and laboratory parameters but different therapies. The traditional approach to the hyponatremic patient relies on volume assessment, but there are limitations to this method.
Methods: We used an algorithm that relies on fractional excretion of urate (FEurate) to evaluate patients with hyponatremia and present 4 illustrative cases.
Results: Overall, 2 patients had increased FEurate [normal: 4-11%], as is seen in SIADH and RSW. A diagnosis of SIADH was made in 1 patient by correcting the hyponatremia with 1.5% saline and observing a characteristic normalization of an elevated FEurate that is characteristic of SIADH as compared to FEurate being persistently increased in RSW. A patient with T-cell lymphoma had symmetrical leg edema due to lymphomatous obstruction of the inferior vena cava, postural hypotension, pleural effusion, ascites, decreased cardiac output and urine sodium level of 10mmol/L. Saline-induced excretion of dilute urines and undetectable plasma antidiuretic hormone were consistent with RSW. Furosemide, given for presumed heart failure, induced a profound diuresis that required large volumes of fluid resuscitation. A normal FEurate identified a reset osmostat in a transplant patient with a slowly developing pneumocystis carinii pneumonia. A volume-depleted hyponatremic patient with Addison׳s disease had a low FEurate of 1.4%.
Conclusions: These illustrative cases suggest that an approach to hyponatremia using FEurate may be a useful alternative to traditional volume-based approaches.
Sumi H, Tominaga N, Fujita Y, Verbalis J Clin Exp Nephrol. 2025; 29(2):134-148.
PMID: 39847311 PMC: 11828805. DOI: 10.1007/s10157-025-02624-9.
The Different Paths That Lead to Hypotonic Hyponatremia, and a Safe Approach to Treatment.
Imbriano L, Grant C, Masani N J Clin Med. 2025; 14(1.
PMID: 39797178 PMC: 11721142. DOI: 10.3390/jcm14010092.
Maesaka J, Imbriano L, Grant C, Miyawaki N Kidney Res Clin Pract. 2023; 43(1):33-46.
PMID: 37919890 PMC: 10846990. DOI: 10.23876/j.krcp.23.092.
Maesaka J, Imbriano L, Grant C, Miyawaki N Biomolecules. 2023; 13(4).
PMID: 37189385 PMC: 10136207. DOI: 10.3390/biom13040638.
Naganuma J, Koyama S, Watabe Y, Yoshihara S J Clin Res Pediatr Endocrinol. 2023; 16(4):489-494.
PMID: 36794751 PMC: 11629720. DOI: 10.4274/jcrpe.galenos.2023.2022-7-16.